Upcoming Funding Opportunities and Biotech News
CBC Invites New Applications
High Throughput Screening (HTS) Supplemental Grant Program
Application Due Date: November 11, 2015
Funding: up to $20,000 per award
▸ HTS Award RFA (rev. 9/29/15)
NEW: CBC-Lever Pilot Projects
Title: In Vivo Studies using Patient-Derived Xenograft Tumor Models
Application Due Date: November 30, 2015
Funding: up to $25,000 per award
Overview: The Patient-Derived Xenograft (PDX) Core Facility is a shared resource created to support the researchers of the Chicago Region Physical Sciences-Oncology Center (CR-PSOC), funded by a $10 million U54 grant from the National Cancer Institute. The Chicago Biomedical Consortium (CBC) awarded a $1.5 million Lever grant in conjunction with the U54 to further enable CR-PSOC investigators to develop and translate innovations deriving from physical sciences approaches to cancer research.
To facilitate broad access to these powerful but expensive new models for human disease, this new core facility has set aside $50,000 of Lever funds to support pilot in vivo studies using PDX models for investigators outside of the CR-PSOC. These in vivo studies will be managed by the Developmental Therapeutics Core within Northwestern’s Center for Developmental Therapeutics.
With questions please contact:
Operations Coordinator, Center for Developmental Therapeutics
Exploratory Workshops Program
Application Due Date: December 4, 2015
Funding: up to $2,000 per award
Chicago Biotech News
- Fostering Innovation In Biotechnology
Northwestern University School of Professional Studies has recently launched a new certificate program: Fostering Innovation in Biotechnology. Registration for the Winter 2016 term is now open.
- CIMposium: ”Commercial Strategy for Startups”
Chicago Innovation Mentors (CIM) is excited to extend an invitation to the entire CBC community to the December 2015 CIMposium! This year’s CIMposium series is titled, "Commercial Strategy for Startups" and is intended to help entrepreneurs prepare their companies to assess market potential and manage market risk. It will demonstrate the importance of translating innovation into a viable commercial product early on, to better communicate product value to strategic and financial partners. The December event will focus on evaluating your market and will take place from 5:30 pm – 8:30 pm on Wednesday, Dec. 2nd and will be held in the Chicago Innovation Exchange Auditorium located at 1452 E 53rd St, Chicago, IL 60615. Registration is FREE and open to the public but there are a limited number of seats, so please RSVP as soon as possible.
Stay Tuned for Future News from the CBC